Table 6.
Healthcare Costs Attributable to Recurrent Clostridium difficile Infection, Overall and by Age, Sex, and Immunocompromising Status
| Characteristic | Healthcare Costs in CDIRECURRENT Cohort, $ (n = 8502) | Healthcare Costs in CDI PRIMARY2 Cohort, $ (n = 8502) | Healthcare Costs Attributable to Recurrent CDI, $ |
|---|---|---|---|
| Overall | 49456 (47847–50997) | 38876 (37550–40291) | 10580 (8849–12446) |
| Age <65 y | 48342 (46013–50858) | 39597 (37595–41831) | 8745 (6039–11354) |
| Age ≥65 y | 50532 (48562–52724) | 38180 (36420–40046) | 12352 (9911–14736) |
| Male | 58552 (55540–61732) | 45528 (43160–48078) | 13024 (9624–16479) |
| Female | 44300 (42528–46019) | 35105 (33603–36772) | 9194 (7110–11166) |
| Not immunocompromised | 39316 (37915–40681) | 30484 (29334–31722) | 8832 (7218–10414) |
| Immunocompromised | 82410 (77362–87666) | 66151 (62112–70403) | 16259 (10726–22207) |
Data are presented as mean (95% confidence interval).
Abbreviations: CDI, Clostridium difficile infection; CDIPRIMARY2, cohort with primary CDI only matched to those with recurrent CDI; CIDRECURRENT, cohort with recurrent CDI.